FR2703053B1
(fr)
*
|
1993-03-26 |
1995-06-16 |
Genset Sa |
Oligonucleotides agrafes et semi-agrafes, procede de preparation et applications .
|
WO1995024477A1
(en)
*
|
1994-03-08 |
1995-09-14 |
City Of Hope |
Human papillomavirus targeted ribozymes
|
US5631148A
(en)
*
|
1994-04-22 |
1997-05-20 |
Chiron Corporation |
Ribozymes with product ejection by strand displacement
|
US5750674A
(en)
*
|
1995-05-23 |
1998-05-12 |
Hybridon, Inc. |
Methods and compounds for the stereoselective enrichment of oligonucleotide diastereomers and oligonucleotides thereby produced
|
US20050042647A1
(en)
*
|
1996-06-06 |
2005-02-24 |
Baker Brenda F. |
Phosphorous-linked oligomeric compounds and their use in gene modulation
|
US6776986B1
(en)
|
1996-06-06 |
2004-08-17 |
Novartis Ag |
Inhibition of HIV-1 replication by antisense RNA expression
|
US20030044941A1
(en)
|
1996-06-06 |
2003-03-06 |
Crooke Stanley T. |
Human RNase III and compositions and uses thereof
|
US5898031A
(en)
*
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
US9096636B2
(en)
|
1996-06-06 |
2015-08-04 |
Isis Pharmaceuticals, Inc. |
Chimeric oligomeric compounds and their use in gene modulation
|
US20050032067A1
(en)
*
|
2002-11-05 |
2005-02-10 |
Prakash Thazha P. |
Non-phosphorous-linked oligomeric compounds and their use in gene modulation
|
US7070925B1
(en)
|
1996-07-16 |
2006-07-04 |
Gen-Probe Incorporated |
Method for determining the presence of an RNA analyte in a sample using a modified oligonucleotide probe
|
AU6592496A
(en)
*
|
1996-07-22 |
1998-02-10 |
Hybridon, Inc. |
Compositions and methods for treating specific gene expression-related diseases and disorders in humans
|
DE19631919C2
(de)
*
|
1996-08-07 |
1998-07-16 |
Deutsches Krebsforsch |
Anti-Sinn-RNA mit Sekundärstruktur
|
US5886165A
(en)
*
|
1996-09-24 |
1999-03-23 |
Hybridon, Inc. |
Mixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segments
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
KR101085210B1
(ko)
|
1998-03-20 |
2011-11-21 |
커먼웰쓰 사이언티픽 앤드 인더스트리얼 리서치 오가니제이션 |
유전자 발현 조절방법
|
AUPP249298A0
(en)
*
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
US20040214330A1
(en)
|
1999-04-07 |
2004-10-28 |
Waterhouse Peter Michael |
Methods and means for obtaining modified phenotypes
|
JP5015373B2
(ja)
†
|
1998-04-08 |
2012-08-29 |
コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション |
改良表現型を得るための方法及び手段
|
US8598332B1
(en)
*
|
1998-04-08 |
2013-12-03 |
Bayer Cropscience N.V. |
Methods and means for obtaining modified phenotypes
|
AU766499B2
(en)
*
|
1998-06-23 |
2003-10-16 |
Medical Research Council |
Structured antisense nucleic acid molecules
|
US6361945B1
(en)
|
1998-07-02 |
2002-03-26 |
Gen-Probe Incorporated |
Molecular torches
|
BR9914773A
(pt)
*
|
1998-10-09 |
2002-02-05 |
Ingene Inc |
Conjunto de elementos genéricos, método para a produção de dna de cordão único, transcrição de mrna, construção de ácido nucléico, transcrição de ssdna, vetor, sistema vetor, célula hospedeira, conjunto para a produção de uma sequência de ácido nucléico de cordão único, método para a produção in vivo ou in vitro de uma sequência de ácido nucléico de cordão único, transcrição de cdna de cordão único, ácido nucléico inibidor, molécula heteroduplex, e composição farmacêutica
|
AU6430599A
(en)
*
|
1998-10-09 |
2000-05-01 |
Cytogenix, Inc. |
Enzymatic synthesis of ssdna
|
US20060172925A1
(en)
*
|
1998-10-26 |
2006-08-03 |
Board Of Regents, The University Of Texas System |
Thio-siRNA aptamers
|
CA2348823A1
(en)
*
|
1998-12-02 |
2000-06-08 |
I.D.M. Immuno-Designed Molecules |
New oligomeric conjugates liable to transfer biological molecules into cells
|
AU776150B2
(en)
|
1999-01-28 |
2004-08-26 |
Medical College Of Georgia Research Institute, Inc. |
Composition and method for (in vivo) and (in vitro) attenuation of gene expression using double stranded RNA
|
AU2008202208C1
(en)
*
|
1999-01-30 |
2014-04-24 |
Alnylam Pharmaceuticals, Inc. |
Method and medicament for inhibiting the expression of a defined gene
|
DE19956568A1
(de)
*
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
FR2790757B1
(fr)
|
1999-03-09 |
2003-08-01 |
Bioalliance Pharma |
Oligonucleotides contenant une sequence antisens stabilises par une structure secondaire et compositions pharmaceutiques les contenant.
|
AU770615B2
(en)
*
|
1999-03-31 |
2004-02-26 |
Hybridon, Inc. |
Pseudo-cyclic oligonucleobases
|
DE19925073C2
(de)
*
|
1999-06-01 |
2001-07-19 |
Stefan Weiss |
Nucleinsäuremoleküle mit spezifischer Erkennung von nativem PrP·S··c·, Herstellung und Verwendung
|
US6423885B1
(en)
|
1999-08-13 |
2002-07-23 |
Commonwealth Scientific And Industrial Research Organization (Csiro) |
Methods for obtaining modified phenotypes in plant cells
|
US7419964B2
(en)
|
1999-09-16 |
2008-09-02 |
Cytogenix, Inc. |
Treatment of HSV-related pathologies using ssDNA
|
GB9925459D0
(en)
|
1999-10-27 |
1999-12-29 |
Plant Bioscience Ltd |
Gene silencing
|
US8017742B2
(en)
*
|
1999-11-10 |
2011-09-13 |
Japan Science And Technology Agency |
Gene carrier
|
DE10100586C1
(de)
*
|
2001-01-09 |
2002-04-11 |
Ribopharma Ag |
Verfahren zur Hemmung der Expression eines Ziegens
|
US7829693B2
(en)
|
1999-11-24 |
2010-11-09 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of a target gene
|
DE10160151A1
(de)
*
|
2001-01-09 |
2003-06-26 |
Ribopharma Ag |
Verfahren zur Hemmung der Expression eines vorgegebenen Zielgens
|
US8273866B2
(en)
|
2002-02-20 |
2012-09-25 |
Merck Sharp & Dohme Corp. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)
|
US7833992B2
(en)
|
2001-05-18 |
2010-11-16 |
Merck Sharpe & Dohme |
Conjugates and compositions for cellular delivery
|
US8202979B2
(en)
|
2002-02-20 |
2012-06-19 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
|
US7491805B2
(en)
|
2001-05-18 |
2009-02-17 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery
|
US20070026394A1
(en)
|
2000-02-11 |
2007-02-01 |
Lawrence Blatt |
Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies
|
JP2003526367A
(ja)
|
2000-03-16 |
2003-09-09 |
ジェネティカ インコーポレイテッド |
Rna干渉の方法とrna干渉組成物
|
US8202846B2
(en)
|
2000-03-16 |
2012-06-19 |
Cold Spring Harbor Laboratory |
Methods and compositions for RNA interference
|
CA2404890C
(en)
|
2000-03-30 |
2013-11-19 |
Whitehead Institute For Biomedical Research |
Rna sequence-specific mediators of rna interference
|
JP2004512020A
(ja)
*
|
2000-06-23 |
2004-04-22 |
イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー |
組換え構築物ならびにこれを遺伝子発現を減少させる際に用いる方法
|
US20030190635A1
(en)
*
|
2002-02-20 |
2003-10-09 |
Mcswiggen James A. |
RNA interference mediated treatment of Alzheimer's disease using short interfering RNA
|
US20080032942A1
(en)
|
2000-08-30 |
2008-02-07 |
Mcswiggen James |
RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
|
BRPI0115814B8
(pt)
*
|
2000-12-01 |
2021-05-25 |
Europaeisches Laboratorium Fuer Molekularbiologie Embl |
moléculas de rna de filamento duplo, seu método de preparação e composição farmacêutica compreendendo as mesmas
|
US8546143B2
(en)
|
2001-01-09 |
2013-10-01 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of a target gene
|
US7423142B2
(en)
|
2001-01-09 |
2008-09-09 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of anti-apoptotic genes
|
US7767802B2
(en)
|
2001-01-09 |
2010-08-03 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of anti-apoptotic genes
|
EP1229134A3
(de)
|
2001-01-31 |
2004-01-28 |
Nucleonics, Inc |
Verwendung von post-transkriptioneller Genabschaltung zur Identifizierung von Nukleinsäuresequenzen die die Funktion einer Zelle beeinflussen
|
US7563618B2
(en)
|
2001-03-23 |
2009-07-21 |
Geron Corporation |
Oligonucleotide conjugates
|
US20050256068A1
(en)
|
2001-05-18 |
2005-11-17 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)
|
WO2003102131A2
(en)
*
|
2002-04-22 |
2003-12-11 |
Sirna Therapeutics Inc. |
Nucleic acid mediated disruption of hiv fusogenic peptide interactions
|
US9994853B2
(en)
|
2001-05-18 |
2018-06-12 |
Sirna Therapeutics, Inc. |
Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
|
WO2003072590A1
(en)
*
|
2002-02-20 |
2003-09-04 |
Sirna Therapeutics, Inc. |
Rna interference mediated inhibition of map kinase genes
|
US7109165B2
(en)
|
2001-05-18 |
2006-09-19 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery
|
WO2003070972A2
(en)
*
|
2002-02-20 |
2003-08-28 |
Sirna Therapeutics Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
US20050014172A1
(en)
|
2002-02-20 |
2005-01-20 |
Ivan Richards |
RNA interference mediated inhibition of muscarinic cholinergic receptor gene expression using short interfering nucleic acid (siNA)
|
WO2003070742A1
(en)
*
|
2002-02-20 |
2003-08-28 |
Ribozyme Pharmaceuticals, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF TELOMERASE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
US20050159378A1
(en)
|
2001-05-18 |
2005-07-21 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)
|
WO2003070917A2
(en)
*
|
2002-02-20 |
2003-08-28 |
Sirna Therapeutics, Inc. |
Rna interference mediated inhibition of myc and myb genes or genes of their respective pathways
|
US20050148530A1
(en)
|
2002-02-20 |
2005-07-07 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
US8008472B2
(en)
|
2001-05-29 |
2011-08-30 |
Merck Sharp & Dohme Corp. |
RNA interference mediated inhibition of human immunodeficiency virus (HIV) gene expression using short interfering nucleic acid (siNA)
|
DE10133858A1
(de)
*
|
2001-07-12 |
2003-02-06 |
Aventis Pharma Gmbh |
Synthetische doppelsträngige Oligonucleotide zur gezielten Hemmung der Genexpression
|
BR0211111A
(pt)
|
2001-07-12 |
2004-06-22 |
Univ Massachusetts |
Molécula de ácido nucleico isolada, vetor, célula hospedeira, transgene, precursor de rna engenheirado, animal transgênico não humano, e, método de induzir a interferência de ácido ribonucleico de um gene alvo em uma célula
|
US7612194B2
(en)
|
2001-07-24 |
2009-11-03 |
Monsanto Technology Llc |
Nucleic acid sequences from Diabrotica virgifera virgifera LeConte and uses thereof
|
CN1604795B
(zh)
|
2001-08-17 |
2010-05-26 |
科勒制药股份公司 |
具有提高的活性的组合基序免疫刺激寡肽
|
DE10163098B4
(de)
*
|
2001-10-12 |
2005-06-02 |
Alnylam Europe Ag |
Verfahren zur Hemmung der Replikation von Viren
|
US7745418B2
(en)
|
2001-10-12 |
2010-06-29 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting viral replication
|
EP3415625A1
(de)
|
2002-02-01 |
2018-12-19 |
Life Technologies Corporation |
Doppelsträngige oligonukleotide
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
US7683165B2
(en)
|
2002-02-20 |
2010-03-23 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
|
US7910724B2
(en)
|
2002-02-20 |
2011-03-22 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)
|
US20090099117A1
(en)
|
2002-02-20 |
2009-04-16 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF MYOSTATIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
AU2003213057A1
(en)
*
|
2002-02-20 |
2003-09-09 |
Ribozyme Pharmaceuticals, Incoporated |
Rna interference mediated inhibition of checkpoint kinase-1 (chk-1) gene expression using short interfering nucleic acid
|
US7700760B2
(en)
|
2002-02-20 |
2010-04-20 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)
|
ATE519774T1
(de)
|
2002-02-20 |
2011-08-15 |
Sirna Therapeutics Inc |
Durch eine störung der rna vermittelte inhibierung der genexpression des hepatitis c virus (hcv) mit kurzer, störender nukleinsäure (short interfering nucleic acid, sina)
|
US8013143B2
(en)
|
2002-02-20 |
2011-09-06 |
Merck Sharp & Dohme Corp. |
RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA)
|
US7683166B2
(en)
|
2002-02-20 |
2010-03-23 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)
|
US7667030B2
(en)
|
2002-02-20 |
2010-02-23 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)
|
US20090253773A1
(en)
|
2002-02-20 |
2009-10-08 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
US7691999B2
(en)
|
2002-02-20 |
2010-04-06 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)
|
AU2003216255A1
(en)
*
|
2002-02-20 |
2003-09-09 |
Ribozyme Pharmaceuticals, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF MDR P-GLYCOPROTEIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
US20090192105A1
(en)
|
2002-02-20 |
2009-07-30 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA)
|
US7893248B2
(en)
|
2002-02-20 |
2011-02-22 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)
|
US7935812B2
(en)
|
2002-02-20 |
2011-05-03 |
Merck Sharp & Dohme Corp. |
RNA interference mediated inhibition of hepatitis C virus (HCV) expression using short interfering nucleic acid (siNA)
|
US7662952B2
(en)
|
2002-02-20 |
2010-02-16 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acid (siNA)
|
US9657294B2
(en)
|
2002-02-20 |
2017-05-23 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
|
US20090253774A1
(en)
|
2002-02-20 |
2009-10-08 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
US7928218B2
(en)
|
2002-02-20 |
2011-04-19 |
Merck Sharp & Dohme Corp. |
RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)
|
US8067575B2
(en)
|
2002-02-20 |
2011-11-29 |
Merck, Sharp & Dohme Corp. |
RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
|
US7897753B2
(en)
|
2002-02-20 |
2011-03-01 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA)
|
US7667029B2
(en)
|
2002-02-20 |
2010-02-23 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)
|
US8258288B2
(en)
|
2002-02-20 |
2012-09-04 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)
|
AU2003213054A1
(en)
*
|
2002-02-20 |
2003-09-09 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF POLYCOMB GROUP PROTEIN EZH2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
AU2003207708A1
(en)
*
|
2002-02-20 |
2003-09-09 |
Sirna Therapeutics, Inc. |
Rna interference mediated inhibition of map kinase genes
|
US7795422B2
(en)
|
2002-02-20 |
2010-09-14 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)
|
AU2003217550A1
(en)
*
|
2002-02-20 |
2003-09-09 |
Ribozyme Pharmaceuticals, Incorporated |
RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR SUPERFAMILY GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
US7928219B2
(en)
|
2002-02-20 |
2011-04-19 |
Merck Sharp & Dohme Corp. |
RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (SINA)
|
US9181551B2
(en)
|
2002-02-20 |
2015-11-10 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
|
US7678897B2
(en)
|
2002-02-20 |
2010-03-16 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)
|
US7928220B2
(en)
|
2002-02-20 |
2011-04-19 |
Merck Sharp & Dohme Corp. |
RNA interference mediated inhibition of stromal cell-derived factor-1 (SDF-1) gene expression using short interfering nucleic acid (siNA)
|
US7897757B2
(en)
|
2002-02-20 |
2011-03-01 |
Merck Sharp & Dohme Corp. |
RNA interference mediated inhibition of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)
|
US7897752B2
(en)
|
2002-02-20 |
2011-03-01 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)
|
SI3222724T1
(sl)
|
2002-08-05 |
2019-03-29 |
Silence Therapeutics Gmbh |
Nadaljnje nove oblike molekul interferenčne RNA
|
US20040241854A1
(en)
|
2002-08-05 |
2004-12-02 |
Davidson Beverly L. |
siRNA-mediated gene silencing
|
AU2012216354B2
(en)
*
|
2002-08-05 |
2016-01-14 |
Silence Therapeutics Gmbh |
Further novel forms of interfering RNA molecules
|
US20080274989A1
(en)
|
2002-08-05 |
2008-11-06 |
University Of Iowa Research Foundation |
Rna Interference Suppression of Neurodegenerative Diseases and Methods of Use Thereof
|
US20050042646A1
(en)
|
2002-08-05 |
2005-02-24 |
Davidson Beverly L. |
RNA interference suppresion of neurodegenerative diseases and methods of use thereof
|
US8729036B2
(en)
|
2002-08-07 |
2014-05-20 |
University Of Massachusetts |
Compositions for RNA interference and methods of use thereof
|
US7956176B2
(en)
|
2002-09-05 |
2011-06-07 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
|
WO2004029212A2
(en)
|
2002-09-25 |
2004-04-08 |
University Of Massachusetts |
In vivo gene silencing by chemically modified and stable sirna
|
EP2272958A1
(de)
|
2002-09-26 |
2011-01-12 |
ISIS Pharmaceuticals, Inc. |
Modulierung von der Forkheadbox O1A-Expression
|
AU2003304278B2
(en)
|
2002-10-16 |
2009-03-12 |
Board Of Regents Of The University Of Texas System |
Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries
|
WO2004041889A2
(en)
|
2002-11-05 |
2004-05-21 |
Isis Pharmaceuticals, Inc. |
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
US8604183B2
(en)
|
2002-11-05 |
2013-12-10 |
Isis Pharmaceuticals, Inc. |
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
|
US9150606B2
(en)
|
2002-11-05 |
2015-10-06 |
Isis Pharmaceuticals, Inc. |
Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
|
US9150605B2
(en)
|
2002-11-05 |
2015-10-06 |
Isis Pharmaceuticals, Inc. |
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
|
US7078234B2
(en)
|
2002-12-18 |
2006-07-18 |
Monsanto Technology Llc |
Maize embryo-specific promoter compositions and methods for use thereof
|
FR2850971B1
(fr)
*
|
2003-02-10 |
2006-08-11 |
Aventis Pharma Sa |
Oligonucleotide antisens inhibant l'expression de la proteine ob-rgrp et procede de detection de composes modifiant l'interaction entre la famille de la proteine ob-rgrp et le recepteur de la leptine
|
CN1836045B
(zh)
|
2003-03-28 |
2012-05-09 |
孟山都技术有限公司 |
用于早期种子发育的新型植物启动子
|
EP1635765B1
(de)
|
2003-05-23 |
2013-07-17 |
Board Of Regents, The University Of Texas System |
Strukturbasiertes und kombinatorisch ausgewähltes oligonucleosid-phosphorothioat und phosphorodithioat aptamer targeting ap-1 transkriptionsfaktoren
|
US7476729B2
(en)
*
|
2003-10-24 |
2009-01-13 |
Institut Curie |
Dbait and uses thereof
|
EP1526177A1
(de)
*
|
2003-10-24 |
2005-04-27 |
Institut Curie |
Nukleinsäuren zur Beeinflussung der Tumorzell Sterblichkeit
|
US8188254B2
(en)
|
2003-10-30 |
2012-05-29 |
Coley Pharmaceutical Gmbh |
C-class oligonucleotide analogs with enhanced immunostimulatory potency
|
DE112004002170T5
(de)
*
|
2003-11-10 |
2007-03-08 |
University Of Utah Research Foundation, Salt Lake City |
Verbesserte Verfahren und Zusammensetzungen für RNA Interferenz
|
EP3427585A1
(de)
*
|
2003-11-26 |
2019-01-16 |
University of Massachusetts |
Sequenzspezifische hemmung der kleinen rna-funktion
|
US7468431B2
(en)
*
|
2004-01-22 |
2008-12-23 |
Isis Pharmaceuticals, Inc. |
Modulation of eIF4E-BP2 expression
|
CA2554212A1
(en)
|
2004-02-10 |
2005-08-25 |
Sirna Therapeutics, Inc. |
Rna interference mediated inhibition of gene expression using multifunctional short interfering nucleic acid (multifunctional sina)
|
US20060075515A1
(en)
*
|
2004-08-11 |
2006-04-06 |
Luethy Michael H |
Enhanced zein reduction in transgenic corn seed
|
ATE480550T1
(de)
|
2004-03-25 |
2010-09-15 |
California Inst Of Techn |
Hybridisierungskettenreaktion
|
US20060041961A1
(en)
|
2004-03-25 |
2006-02-23 |
Abad Mark S |
Genes and uses for pant improvement
|
US20060021087A1
(en)
|
2004-04-09 |
2006-01-26 |
Baum James A |
Compositions and methods for control of insect infestations in plants
|
CA2566462A1
(en)
*
|
2004-05-12 |
2005-12-01 |
Kamel Khalili |
Compositions and methods for sirna inhibition of primate polyomavirus genes
|
US10508277B2
(en)
|
2004-05-24 |
2019-12-17 |
Sirna Therapeutics, Inc. |
Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
|
AU2005247509C1
(en)
|
2004-05-27 |
2012-09-20 |
Alnylam Pharmaceuticals, Inc. |
Nuclease resistant double-stranded ribonucleic acid
|
US8394947B2
(en)
|
2004-06-03 |
2013-03-12 |
Isis Pharmaceuticals, Inc. |
Positionally modified siRNA constructs
|
US20060075522A1
(en)
|
2004-07-31 |
2006-04-06 |
Jaclyn Cleveland |
Genes and uses for plant improvement
|
US7884086B2
(en)
|
2004-09-08 |
2011-02-08 |
Isis Pharmaceuticals, Inc. |
Conjugates for use in hepatocyte free uptake assays
|
TWI386225B
(zh)
|
2004-12-23 |
2013-02-21 |
Alcon Inc |
用於治療眼睛病症的結締組織生長因子(CTGF)RNA干擾(RNAi)抑制技術
|
CN101124339A
(zh)
*
|
2004-12-30 |
2008-02-13 |
托德·M·豪泽 |
使用自我保护寡核苷酸调节基因表达的组合物和方法
|
EP2489726A3
(de)
|
2005-01-12 |
2012-11-28 |
Monsanto Technology LLC |
Gene und ihre Verwendung zur Pflanzenverbesserung
|
US7727721B2
(en)
|
2005-03-08 |
2010-06-01 |
California Institute Of Technology |
Hybridization chain reaction amplification for in situ imaging
|
ATE552343T1
(de)
|
2005-04-19 |
2012-04-15 |
Basf Plant Science Gmbh |
Endosperm-spezifische expression und/oder expression in keimenden embryos monokotyledoner pflanzen
|
JPWO2006132204A1
(ja)
|
2005-06-06 |
2009-01-08 |
アンジェスMg株式会社 |
転写因子デコイ
|
US9297036B2
(en)
|
2005-07-01 |
2016-03-29 |
Agilent Technologies, Inc |
Nucleic acid probes for analysis of small RNAs and other polynucleotides
|
PL2431473T3
(pl)
|
2005-09-16 |
2017-05-31 |
Monsanto Technology Llc |
Sposoby genetycznej kontroli inwazji owadów u roślin i kompozycje do tego przeznaczone
|
CA2622671C
(en)
|
2005-09-16 |
2020-12-22 |
Devgen Nv |
Methods for controlling pests using rnai
|
CA2622660C
(en)
|
2005-09-16 |
2017-11-07 |
Devgen Nv |
Transgenic plant-based methods for plant pests using rnai
|
ATE526975T1
(de)
*
|
2005-10-07 |
2011-10-15 |
California Inst Of Techn |
Pkr-aktivierung mittels hybridisierungskettenreaktion
|
WO2007072909A1
(ja)
|
2005-12-22 |
2007-06-28 |
Anges Mg, Inc. |
新規オリゴヌクレオチド及びそれから成るNF-κBデコイ
|
CA2637254A1
(en)
|
2006-01-17 |
2007-07-26 |
Biolex Therapeutics, Inc. |
Compositions and methods for humanization and optimization of n-glycans in plants
|
US7754475B2
(en)
*
|
2006-01-25 |
2010-07-13 |
Agilent Technologies, Inc. |
Nucleic acid probes and microarrays for analysis of polynucleotides
|
AU2007211082B2
(en)
|
2006-01-27 |
2012-09-27 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for the use in modulation of microRNAs
|
BRPI0707626A2
(pt)
|
2006-02-10 |
2011-05-10 |
Monsanto Technology Llc |
identificaÇço e uso de genes alvos para o controle de nematàides parasitas de plantas
|
CA2836368C
(en)
|
2006-02-13 |
2020-04-07 |
Monsanto Technology Llc |
Method for managing crop pest resistance
|
EP1986697B1
(de)
*
|
2006-02-17 |
2016-06-29 |
GE Healthcare Dharmacon, Inc. |
Zusammensetzungen und verfahren zur hemmung einer genverstummung durch rna-interferenz
|
WO2007131232A2
(en)
*
|
2006-05-05 |
2007-11-15 |
Isis Pharmaceuticals, Inc. |
Compositions and their uses directed to ptpr alpha
|
CN101195821A
(zh)
|
2006-12-04 |
2008-06-11 |
中国科学院上海生命科学研究院 |
利用RNAi技术改良植物抗虫性的方法
|
US20100093836A1
(en)
|
2007-01-29 |
2010-04-15 |
Isis Pharmaceuticals, Inc |
Compounds and methods for modulating protein expression
|
CA2675926A1
(en)
|
2007-02-16 |
2008-08-21 |
Basf Plant Science Gmbh |
Nucleic acid sequences for regulation of embryo-specific expression in monocotyledonous plants
|
WO2008106658A2
(en)
|
2007-03-01 |
2008-09-04 |
California Institute Of Technology |
TRIGGERED RNAi
|
WO2008144562A1
(en)
|
2007-05-16 |
2008-11-27 |
California Institute Of Technology |
A versatile nucleic acid hairpin motif for programming biomolecular self-assembly pathways
|
CN101821412A
(zh)
*
|
2007-08-15 |
2010-09-01 |
艾德拉药物股份有限公司 |
Toll样受体调控剂
|
US8497364B2
(en)
|
2008-02-27 |
2013-07-30 |
California Institute Of Technology |
Triggered RNAi
|
US8241854B2
(en)
|
2008-05-22 |
2012-08-14 |
California Institute Of Technology |
Triggered RNAi
|
JP5559159B2
(ja)
*
|
2008-06-11 |
2014-07-23 |
バイオニュークレオン ソチエタ・レスポンサビリタ・リミタータ |
修飾オリゴヌクレオチドを使用するhrp−3の阻害
|
US20100233270A1
(en)
|
2009-01-08 |
2010-09-16 |
Northwestern University |
Delivery of Oligonucleotide-Functionalized Nanoparticles
|
MX2011011076A
(es)
|
2009-04-20 |
2011-11-18 |
Monsanto Technology Llc |
Resistencia a multiples virus en plantas.
|
US9145556B2
(en)
|
2010-04-13 |
2015-09-29 |
Life Technologies Corporation |
Compositions and methods for inhibition of nucleic acids function
|
US8658780B2
(en)
|
2010-05-18 |
2014-02-25 |
California Institute Of Technology |
Triggered covalent probes for imaging and silencing genetic expression
|
US9834439B2
(en)
|
2010-07-20 |
2017-12-05 |
California Institute Of Technology |
Biomolecular self-assembly
|
US8877438B2
(en)
|
2010-07-20 |
2014-11-04 |
California Institute Of Technology |
Self-assembled polynucleotide structure
|
US8962241B2
(en)
|
2010-07-20 |
2015-02-24 |
California Institute Of Technology |
Triggered molecular geometry based bioimaging probes
|
WO2012027206A1
(en)
|
2010-08-24 |
2012-03-01 |
Merck Sharp & Dohme Corp. |
SINGLE-STRANDED RNAi AGENTS CONTAINING AN INTERNAL, NON-NUCLEIC ACID SPACER
|
US9260471B2
(en)
|
2010-10-29 |
2016-02-16 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
|
BRPI1107332A2
(pt)
|
2010-12-30 |
2018-10-30 |
Dow Agrosciences Llc |
polinucleotídeo, vetor de transformação, moléculas de ácido nucleico, célula, bem como métodos para controle de praga coleóptera, para aperfeiçoamento do rendimento de cultura de milho, e para produção de célula e planta resistentes à praga coleóptera
|
EP3354735A1
(de)
|
2010-12-30 |
2018-08-01 |
Dow AgroSciences LLC |
Auf kleines rho1-gtp-bindendes protein abzielende und resistenz gegenüber coleopteran-schädlingen verleihende nukleinsäuremoleküle
|
UY33851A
(es)
|
2010-12-30 |
2012-07-31 |
Dow Agrosciences Llc |
Moléculas de ácido nucleico que confieren resistencia a las plagas de coleópteros
|
BRPI1107329A2
(pt)
|
2010-12-30 |
2019-11-19 |
Dow Agrosciences Llc |
moléculas de ácido nucléico que direcionadas à subunidade h de atpase vacuolar que conferem resistência a pragas de coleópteros, vetor de transformação de planta, célula transformada, bem como métodos para controlar uma população de praga de coleóptero, controlar uma infestação pela dita praga, melhorar o rendimento de uma safra e para produzir uma célula transgênica
|
DK2790736T3
(en)
|
2011-12-12 |
2018-05-07 |
Oncoimmunin Inc |
In vivo delivery of oligonucleotides
|
US9688983B2
(en)
|
2012-12-20 |
2017-06-27 |
Dow Agrosciences Llc |
Nucleic acid molecules that confer resistance to coleopteran pests
|
EP2810952A1
(de)
|
2013-06-03 |
2014-12-10 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Neuartige Schädlingsbekämpfungsverfahren
|
US9856472B2
(en)
|
2013-07-01 |
2018-01-02 |
California Institute Of Technology |
Small conditional RNAs
|
WO2015023975A1
(en)
*
|
2013-08-16 |
2015-02-19 |
Rana Therapeutics, Inc. |
Compositions and methods for modulating rna
|
BR102014031844A2
(pt)
|
2013-12-20 |
2015-10-06 |
Dow Agrosciences Llc |
ras oposto (rop) e moléculas de ácido nucleico relacionadas que conferem resistência a pragas de coleópteros e hemípteros
|
MX2016008263A
(es)
|
2013-12-20 |
2017-05-09 |
Dow Agrosciences Llc |
Moleculas de acido nucleico rnapii 140 que confieren resistencia a plagas de coleopteros.
|
MX366975B
(es)
|
2014-03-12 |
2019-08-01 |
Univ Sydney |
Produccion de arn en plantas superiores.
|
AU2015255995B2
(en)
|
2014-05-07 |
2018-05-10 |
Dow Agrosciences Llc |
Dre4 nucleic acid molecules that confer resistance to coleopteran pests
|
CN105087554B
(zh)
*
|
2014-05-14 |
2017-09-22 |
武汉大学 |
Dna磷硫酰化修饰基因簇
|
TR201908550T4
(tr)
|
2014-06-04 |
2019-07-22 |
Exicure Inc |
Profilaktik veya terapötik uygulamalar için lipozomal sferik nükleik asitler tarafından immün modülatörlerin çok değerlikli teslimi.
|
US20160194658A1
(en)
|
2014-12-22 |
2016-07-07 |
Dow Agrosciences Llc |
Nucampholin nucleic acid molecules to control coleopteran insect pests
|
WO2016130943A1
(en)
|
2015-02-13 |
2016-08-18 |
Rana Therapeutics, Inc. |
Hybrid oligonucleotides and uses thereof
|
EP3067424A1
(de)
|
2015-03-13 |
2016-09-14 |
Dow AgroSciences LLC |
Rna-polymerase-i1-nukleinsäuremoleküle zur kontrolle von insektenschädlingen
|
US20180105832A1
(en)
|
2015-04-13 |
2018-04-19 |
Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. |
Novel aflatoxin and fungal infection control methods
|
BR102016012010A2
(pt)
|
2015-05-29 |
2020-03-24 |
Dow Agrosciences Llc |
Molécula de ácido nucleico, de ácido ribonucleico (rna) e de ácido ribonucleico de filamento duplo (dsrna), usos de célula, planta e semente, produto primário, bem como métodos para controlar uma população de pragas coleópteras e/ou hemípteras, para melhorar o rendimento de uma cultura, e para produzir uma célula vegetal transgênica e uma planta transgênica
|
CN108431207A
(zh)
|
2015-10-12 |
2018-08-21 |
美国陶氏益农公司 |
赋予对鞘翅目和半翅目害虫的抗性的wupa核酸分子
|
AU2016371636A1
(en)
|
2015-12-18 |
2018-06-21 |
Dow Agrosciences Llc |
Ribosomal protein L40 (RPL40) nucleic acid molecules that confer resistance to coleopteran and hemipteran pests
|
ES2908919T3
(es)
|
2016-07-05 |
2022-05-04 |
California Inst Of Techn |
Reacción en cadena de hibridación de iniciador fraccionario
|
AU2017321492A1
(en)
|
2016-08-30 |
2019-03-14 |
California Institute Of Technology |
Immunohistochemistry via hybridization chain reaction
|
WO2018089237A1
(en)
|
2016-11-10 |
2018-05-17 |
Dow Agrosciences Llc |
Cytochrome b (cytb) nucleic acid molecules that control pathogens
|
EP3342780A1
(de)
|
2016-12-30 |
2018-07-04 |
Dow AgroSciences LLC |
Nukleinsäuremoleküle mit prä-mrna-verarbeitungsfaktor 8 (prp8) zur kontrolle von insektenschädlingen
|
WO2018201090A1
(en)
*
|
2017-04-28 |
2018-11-01 |
Exicure, Inc. |
Synthesis of spherical nucleic acids using lipophilic moieties
|
EP3825408A1
(de)
|
2019-11-19 |
2021-05-26 |
FRAUNHOFER-GESELLSCHAFT zur Förderung der angewandten Forschung e.V. |
Verfahren zur insektenschädlingsbekämpfung für mehrere arten
|
EP4284925A1
(de)
|
2021-01-26 |
2023-12-06 |
California Institute of Technology |
Allosterische bedingte guide-rnas zur zellselektiven regulierung von crispr/cas
|